ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs
The dataset powers our Rx Inspector tool, which lets you find the factories that made your generic drugs and their FDA inspection track records.
Big Pharma Is Making Mexico Sick. Medicine and Supply Shortages Are Rampant.
Mexico manufactures medical devices and medicines, but the majority are exported, leaving residents facing shortages.
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs
A ProPublica investigation found that for more than a decade, the FDA gave substandard factories banned from the United States a special pass to keep sending drugs to an unsuspecting…
Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
The gene therapy Zolgensma helped children born with a fatal disease, spinal muscular atrophy, grow up to run and play. But the cost was stunning: $2 million per dose.
And the Winners of the 2024 Shkreli Awards for Worst Healthcare Profiteering Are…
"All these stories paint a picture of a healthcare industry in desperate need of transformation," said the head of the think tank behind the awards.
UnitedHealthcare Tried to Deny Coverage to a Chronically Ill Patient. He Fought Back, Exposing the Insurer’s Inner Workings
After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden…
US Drug Prices Still Far Higher Than Other Nations’ Even After Medicare Talks
The U.S. "has always accepted that we are the country that overpays relative to the rest of the world," said one health policy expert.
New York Times Sinks to New Low in Its Psychiatric Coverage
By Bruce E. Levine / CounterPunch For those familiar with the disastrous New York Times reporting of weapons of mass destruction (WMDs) in Iraq, it will be no great surprise…
Addressing Neglected Diseases: Can Non-Profits Bridge Pharma’s Investment Gap?
Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing…
Public Pharma for Europe, a Game-Changer for Access to Medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin
By Bruce E. Levine / CounterPunch “. . . if the major media picks up on this story, they will have the chance to report on what arguably is the…
Sidney Wolfe: The Doctors’ Doctor for Prevention and Accountability
By Ralph Nader / Nader.org With the passing of Dr. Sidney M. Wolfe at the age of 86, our country has lost one of the greatest “extra-ordinary” physicians of the…
Ukraine’s Reconstruction in BlackRock’s Hands & Gabor Maté on Explosion of Antidepressants
After Ukraine's infrastructure is destroyed by NATO's proxy war against Russia, corporations like BlackRock and J.P. Morgan plan to work with corrupt Ukrainian officials under martial law to seize the…